United KingdomResearchers developed an AI-driven framework called EscapeMap to predict and design SARS-CoV-2 variants that could evade existing antibodies. The system combines evolutionary data, biophysical modeling, and immune selection principles to simulate how the virus might evolve under immune pressure. By analyzing patterns in viral mutation and antibody interaction, EscapeMap generated 22 artificial viral proteins, 11 of which were shown to express as stable, functional proteins capable of escaping prevalent antibodies. The study highlights the ongoing challenge of combating viral evolution and underscores the importance of proactive therapeutic development.
Bias read (Center): The article presents scientific research without overt ideological framing. While it discusses the implications of AI-driven viral evolution, it does not take a partisan stance on policy solutions or societal impacts. The focus remains on technical advancements and their medical relevance ratherthan
